Pietro Bulian Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

3/2010

Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Bulian Research Topics

Disease

17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2022 - 03/2006
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2012 - 01/2008
2	Lymphoma (Lymphomas) 12/2017 - 01/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019
1	Neoplasms (Cancer) 01/2018
1	Lymphocytosis 01/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2017
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Residual Neoplasm 10/2014
1	Pathologic Complete Response 10/2014
1	Corneal Neovascularization 04/2013
1	Headache (Headaches) 03/2010
1	Meningitis 03/2010
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2010
1	Anemia 04/2004
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 04/2004

Drug/Important Bio-Agent (IBA)

4	Rituximab (Mabthera)FDA Link 01/2016 - 02/2012
4	Biological ProductsIBA 02/2012 - 01/2008
3	ibrutinibIBA 05/2022 - 01/2018
3	fludarabineIBA 10/2015 - 02/2012
3	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2012 - 07/2006
3	Surface Antigens (Surface Antigen)IBA 01/2011 - 03/2006
3	Proteins (Proteins, Gene)FDA Link 01/2010 - 07/2006
2	ChemokinesIBA 01/2018 - 05/2009
2	IntegrinsIBA 01/2018 - 01/2016
1	serum P-component (CIt)IBA 10/2021
1	Integrin alpha4beta1 (VLA-4)IBA 01/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2017
1	Antiviral Agents (Antivirals)IBA 01/2016
1	Natalizumab (Tysabri)FDA Link 01/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015
1	Proteoglycans (Proteoglycan)IBA 04/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2010
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2009
1	Integrin alpha4IBA 01/2008
1	Immunoglobulins (Immunoglobulin)IBA 01/2008
1	Hemoglobins (Hemoglobin)IBA 04/2004

Therapy/Procedure

3	Therapeutics 01/2016 - 04/2004
3	Time-to-Treatment 01/2012 - 01/2008
1	Radiotherapy 12/2017
1	Drug Therapy (Chemotherapy) 02/2012